GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
61 hedge funds and large institutions have $88.7M invested in Genocea Biosciences, Inc. in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $69K
Holders
61
Holding in Top 10
1
Calls
$1K
Puts
$69K
Top Buyers
| 1 | +$5.98M | |
| 2 | +$1.8M | |
| 3 | +$1.39M | |
| 4 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$613K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$547K |
Top Sellers
| 1 | -$2.92M | |
| 2 | -$1.36M | |
| 3 | -$816K | |
| 4 |
Millennium Management
New York
|
-$321K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$271K |